Literature DB >> 3518781

Cellular basis of host defence in pyelonephritis. II. Acute infection.

T E Miller, G Findon, S Cawley, I Clarke.   

Abstract

We have investigated the cellular basis of host defence mechanisms in experimental pyelonephritis. Cellular components of the host defence system were depleted using cyclophosphamide, methylprednisolone or radiation. Depletion of cellular competence did not affect the course of infection during the first 16 h after challenge with Escherichia coli, but after 96 h up to a 1000-fold increase in bacterial numbers in the kidneys of cytodepleted animals was demonstrable. When quantitative aspects of the relationship between cellular competence and host defence were studied, it was found that severe depletion of cellular components was necessary before host defence mechanisms were adversely affected. Thus while cellular mechanisms are quantitatively adequate and contribute to host defence in pyelonephritis they have little impact on the immediate post-infection phase. Non-cellular factors however, do limit bacterial proliferation in the acute phase and may be important determinants in the biology of pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3518781      PMCID: PMC2013153     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  13 in total

1.  Increased susceptibility to pyelonephritis during acute hypertension by angiotensin II and norepinephrine.

Authors:  R K JONES; A P SHAPIRO
Journal:  J Clin Invest       Date:  1963-02       Impact factor: 14.808

2.  Experimental pyelonephritis: a new method for inducing pyelonephritis in the rat.

Authors:  T E Miller; K B Robinson
Journal:  J Infect Dis       Date:  1973-03       Impact factor: 5.226

3.  Local synthesis of secretory IgA in experimental pyelonephritis.

Authors:  J W Smith; W L Hand; J P Sanford
Journal:  J Immunol       Date:  1972-04       Impact factor: 5.422

4.  Prevention of chronic experimental pyelonephritis by suppression of acute suppuration.

Authors:  M P Glauser; J M Lyons; A I Braude
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

Review 5.  Biology and pathology of urinary tract infections.

Authors:  L A Hanson; A Fasth; U Jodal; B Kaijser; C Svanborg Edén
Journal:  J Clin Pathol       Date:  1981-07       Impact factor: 3.411

6.  Role of granulocytes in the prevention and therapy of experimental Streptococcus sanguis endocarditis in rabbits.

Authors:  M J Meddens; J Thompson; H Mattie; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

7.  Prevention of scarring in experimental pyelonephritis in the rat by early antibiotic therapy.

Authors:  I N Slotki; A W Asscher
Journal:  Nephron       Date:  1982       Impact factor: 2.847

8.  Experimental pneumococcal meningitis: role of leukocytes in pathogenesis.

Authors:  J D Ernst; J M Decazes; M A Sande
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

9.  Pyelonephritis: the relationship between infection, renal scarring, and antimicrobial therapy.

Authors:  T Miller; S Phillips
Journal:  Kidney Int       Date:  1981-05       Impact factor: 10.612

10.  Pyelonephritis: the role of cell-mediated immunity defined in a congenitally athymic rat.

Authors:  T Miller
Journal:  Kidney Int       Date:  1984-12       Impact factor: 10.612

View more
  5 in total

1.  A low molecular weight component derived from the milk of hyperimmunised cows suppresses inflammation by inhibiting neutrophil emigration.

Authors:  D J Ormrod; T E Miller
Journal:  Agents Actions       Date:  1992-09

2.  Aggravation by morphine and D-aspartic acid of pyelonephritis induced by i.v. inoculation of Staphylococcus aureus in rats.

Authors:  H Koyuncuoğlu; M Güngör; O Anğ; D Inanç; M Anğ-Küçüker; H Sağduyu; V Uysal
Journal:  Infection       Date:  1988       Impact factor: 3.553

3.  Cellular basis of host defence in pyelonephritis. III. Deletion of individual components.

Authors:  T E Miller; G Findon; S Cawley
Journal:  Br J Exp Pathol       Date:  1987-06

4.  L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis.

Authors:  M Tardif; D Beauchamp; Y Bergeron; C Lessard; P Gourde; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

5.  An animal model for chronic infection of the unobstructed urinary tract.

Authors:  T E Miller; J P Lecamwasam; D J Ormrod; G Findon; J Cornish
Journal:  Br J Exp Pathol       Date:  1987-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.